Table 1.
Seven significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for mRNAs in type 1 diabetes mellitus (T1DM) related competing endogenous (ceRNA) regulatory network
| Term | Count | P value | Genes |
|---|---|---|---|
| *hsa04070:Phosphatidylinositol signaling system | 4 | 4.567E−04 | INPP4A, PIP4K2A, PIP4K2C, CALM1 |
| hsa00562:Inositol phosphate metabolism | 3 | 2.504E−03 | INPP4A, PIP4K2A, PIP4K2C |
| hsa00512:Mucin type O-Glycan biosynthesis | 2 | 1.029E−02 | GALNT2, GALNT11 |
| hsa04012:ErbB signaling pathway | 2 | 2.636E−02 | CBLB, EREG |
| hsa00564:Glycerophospholipid metabolism | 2 | 2.842E−02 | GPD1L, LPCAT1 |
| *hsa04728:Dopaminergic synapse | 2 | 3.634E−02 | PPP2R5C, CALM1 |
| *hsa04910:Insulin signaling pathway | 2 | 3.856E−02 | CBLB, CALM1 |
*The pathway overlapping with T1DM-related pathways retrieved from Comparative Toxicogenomics Database (CTD)